CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to three new employees with a grant date of February 24, 2021, as equity inducement awards outside of the Company's Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Restated 2017 Equity Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved on February 24, 2021, in accordance with Nasdaq Listing Rule 5635(c)(4).
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News provided by
Share this article
Share this article
SEATTLE, Feb. 10, 2021 /PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees with a grant date of February 10, 2021, as equity inducement awards outside of the Company s Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Restated 2017 Equity Incentive Plan) and material to the employees acceptance of employment with the company. The equity awards were approved on February 10, 2021, in accordance with Nasdaq Listing Rule 5635(c)(4).
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News provided by
Share this article
Share this article
SEATTLE, Jan. 28, 2021 /PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees with a grant date of January 28, 2021, as equity inducement awards outside of the Company s Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Restated 2017 Equity Incentive Plan) and material to the employees acceptance of employment with the company. The equity awards were approved on January 28, 2021, in accordance with Nasdaq Listing Rule 5635(c)(4).